Scalper1 News
Regenxbio (RGNX) popped on the first trading day of its upsized initial public offering, which raised $138.6 million for the drugmaker. Regenxbio priced at 22 and opened at 30.26, up 38%, and remained near there in midday trading. It had previously set a price range of 17 to 19. The biotech company offered 6.3 million shares, above previous plans to offer 5.6 million shares. Regenxbio is focused on developing, commercializing and licensing Scalper1 News
Scalper1 News